BamSEC and AlphaSense Join Forces
Learn More

Eledon Pharmaceuticals Inc.

NASDAQ: ELDN    
Share price (1/6/25): $4.64    
Market cap (1/6/25): $277 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 16 pages Pre-Funded Warrant to Purchase Common Stock Eledon Pharmaceuticals, Inc
12/34/56
EX-4.11
from S-3 41 pages Eledon Pharmaceuticals, Inc. Indenture Dated as of , 20 [ ] Trustee Subordinated Securities
12/34/56
EX-4.10
from S-3 41 pages Eledon Pharmaceuticals, Inc. Indenture Dated as of , 20 [ ] Trustee Senior Debt Securities
12/34/56
EX-4.1
from 8-K 19 pages Pre-Funded Warrant to Purchase Common Stock Eledon Pharmaceuticals, Inc
12/34/56
EX-4
from 8-K 21 pages Tranche a Warrant to Purchase Common Stock or Pre-Funded Warrants Eledon Pharmaceuticals, Inc
12/34/56
EX-4
from 8-K 19 pages Pre-Funded Warrant to Purchase Common Stock Eledon Pharmaceuticals, Inc
12/34/56
EX-4.5
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.4
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.3
from S-3 60 pages Eledon Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.5
from 10-K 3 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from S-3 56 pages Eledon Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.4
from 10-K 3 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 18 pages Common Stock Purchase Warrant Novus Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 19 pages Common Stock Purchase Warrant Novus Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 19 pages Series [A/B] Common Stock Purchase Warrant Novus Therapeutics, Inc
12/34/56
EX-4.5
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.4
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.3
from S-3 60 pages Novus Therapeutics, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.2
from S-3 56 pages Novus Therapeutics, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from 8-A12B/A 2 pages Indenture or similar
12/34/56